EPIDIOLEX, Continues DelveInsight Business Research, LLP United States of America United Kingdom 07.08.2025 - 18:06:27 EPIDIOLEX Continues to Lead the Way in Cannabinoid-Based Epilepsy Treatment | DelveInsight +14699457679Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg View original content:https://www.prnewswire.co.uk/news-releases/epidiolex-continues-to-lead-the-way-in-cannabinoid-based-epilepsy-treatment--delveinsight-302443662.html